Cecropia hololeuca: A new source of compounds with potential anti-inflammatory action

Nat Prod Res. 2021 Aug;35(16):2772-2777. doi: 10.1080/14786419.2019.1663512. Epub 2019 Sep 11.

Abstract

Our objective is to investigate the phytochemical components, antioxidant capacity and in vitro and in vivo anti-inflammatory action from Cecropia hololeuca bark aqueous extract (AECh). The chemical characterization of AECh was performed through CE-UV, FTIR and NMR Spectroscopy. In vitro assays were performed with the AECh on murine macrophages J774A.1 cells in order to analyse cell viability, NO, TNF-α and IL-1β productions and the in vivo anti-inflammatory potential in acute carrageenan paw oedema in mice. The AECh showed a decrease in the production of NO, TNF-α and IL-1β, without altering the cell viability and reduction of the paw thickness in the 2nd, 3rd and 4th hour. The extract presented 72% free radical scavenging, 0.60% flavonoid content and showed the presence of gallic acid, caffeic acid and catechin as major constituents. The C. hololeuca bark extract showed important antioxidant and anti-inflammatory activity, emphasizing the industrial and pharmacological potential of this plant.

Keywords: Cecropia hololeuca; anti-inflammatory; cytotoxicity; phenolic compounds.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / isolation & purification
  • Anti-Inflammatory Agents* / pharmacology
  • Antioxidants* / isolation & purification
  • Antioxidants* / pharmacology
  • Carrageenan
  • Cecropia Plant / chemistry*
  • Cell Line
  • Edema / chemically induced
  • Edema / drug therapy
  • Mice
  • Plant Bark / chemistry
  • Plant Extracts* / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Plant Extracts
  • Carrageenan